» Articles » PMID: 18728801

Differential Diagnoses and Management Strategies in Patients with Schizophrenia and Bipolar Disorder

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2008 Aug 30
PMID 18728801
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Successful treatment of psychiatric disorders, including bipolar disorder and schizophrenia, is complicated and is affected by a broad range of factors associated with the diagnosis, choice of treatment and social factors. In these patients, treatment management must focus on accurate and early diagnosis, to ensure that correct treatment is administered as soon as possible. In both disorders, the treatment of the disease in the acute phase must be maintained long term to provide continuous relief and normal function; the treatment choice in the early stages of the disease may impact on long-term outcomes. In schizophrenia, treatment non-compliance is an important issue, with up to 50% of patients discontinuing treatment for reasons as diverse as efficacy failure, social barriers, and more commonly, adverse events. Treatment non-compliance also remains an issue in bipolar disorder, as tolerability of mood stabilizers, especially lithium, is not always good, and combination treatments are frequent. In order to achieve an optimal outcome in which the patient continues with their medication life-long, treatment should be tailored to each individual, taking into account treatment and family history, and balancing efficacy with tolerability to maximize patient benefit and minimize the risk of discontinuation. These case studies illustrate how treatment should be monitored, tailored and often changed over time to meet these needs.

Citing Articles

E-Screening for Prenatal Depression in Kampala, Uganda Using the Edinburgh Postnatal Depression Scale: Survey Results.

Namatovu H, Magumba M, Akena D Online J Public Health Inform. 2025; 17():e51602.

PMID: 39810415 PMC: 11750128. DOI: 10.2196/51602.


Are There Any Differences in Clinical and Biochemical Variables between Bipolar Patients with or without Lifetime Psychotic Symptoms?.

Esposito C, Barkin J, Ceresa A, Nosari G, Di Paolo M, Legnani F J Clin Med. 2023; 12(18).

PMID: 37762843 PMC: 10531939. DOI: 10.3390/jcm12185902.


Correlates of long duration of untreated illness (DUI) in patients with bipolar disorder: results of an observational study.

Salvo G, Porceddu G, Albert U, Maina G, Rosso G Ann Gen Psychiatry. 2023; 22(1):12.

PMID: 36959643 PMC: 10035162. DOI: 10.1186/s12991-023-00442-5.


Misdiagnosis, detection rate, and associated factors of severe psychiatric disorders in specialized psychiatry centers in Ethiopia.

Ayano G, Demelash S, Yohannes Z, Haile K, Tulu M, Assefa D Ann Gen Psychiatry. 2021; 20(1):10.

PMID: 33531016 PMC: 7856725. DOI: 10.1186/s12991-021-00333-7.


Cell type-specific transcriptional programs in mouse prefrontal cortex during adolescence and addiction.

Bhattacherjee A, Djekidel M, Chen R, Chen W, Tuesta L, Zhang Y Nat Commun. 2019; 10(1):4169.

PMID: 31519873 PMC: 6744514. DOI: 10.1038/s41467-019-12054-3.


References
1.
Baethge C, Baldessarini R, Mathiske-Schmidt K, Hennen J, Berghofer A, Muller-Oerlinghausen B . Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005; 66(2):174-82. DOI: 10.4088/jcp.v66n0204. View

2.
Muller M, WETZEL H, Benkert O . Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis. Int Clin Psychopharmacol. 2002; 17(5):249-61. DOI: 10.1097/00004850-200209000-00005. View

3.
Hantouche E, Akiskal H, Azorin J, Chatenet-Duchene L, Lancrenon S . Clinical and psychometric characterization of depression in mixed mania: a report from the French National Cohort of 1090 manic patients. J Affect Disord. 2006; 96(3):225-32. DOI: 10.1016/j.jad.2005.01.005. View

4.
Geddes J, Freemantle N, Harrison P, Bebbington P . Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000; 321(7273):1371-6. PMC: 27538. DOI: 10.1136/bmj.321.7273.1371. View

5.
Meyer J, Koro C . The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res. 2004; 70(1):1-17. DOI: 10.1016/j.schres.2004.01.014. View